reports
Quarterly Review
M&G Credit Income Investment Trust plc (MGCI) Quarterly Review 26-Apr-2024 / 12:18 GMT/BST M&G CREDIT INCOME INVESTMENT TRUST PLC (the “Company”) LEI: 549300E9W63X1E5A3N24 Quarterly Review The Company announces that its quarterly review as at 31 March 2024 is now available, a summary of which is provided below. The full quarterly review is available on the Company’s website at: Market Review The first quarter of the year saw further declines in inflation across most major economies, however with progress slower than expected, market sentiment turned to ...
Qifu Technology Filed 2023 Annual Report on Form 20-F
Qifu Technology Filed 2023 Annual Report on Form 20-F SHANGHAI, China, April 26, 2024 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading Credit-Tech platform in China, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission on April 26, 2024. The annual report can be accessed on the Company’s investor relations website at as well as the SEC’s website at . The Company will provide a hard copy of the annual report containing...
Dividend payment ex-date
Dividend payment ex-date The Annual General Meeting of Shareholders of Grigeo AB (trading code GRG1L, ISIN code LT0000102030, hereinafter - the Company) was held on 26th April 2024. The rights accounting day of the shareholders of the General Meeting of Shareholders is 13th May 2024. The proprietary rights will be held by the persons who, at the close of the tenth working day after the General Meeting of Shareholders which adopted the appropriate decision, i.e. on 13th May 2024, will be the shareholders of the Company. Proceeding from the above, the ex-date is 10th May 2024. From that date...
Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 o...
Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA) Decision by EMA follows recent judgment by the Court of Justice of the European Union regarding the organization of EMA’s expert groupsApellis anticipates a CHMP opinion no later than July 2024 WALTHAM, Mass., April 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the European Medicines Agency (EMA) has reset the review of the marketing authorization application (MAA) for intravitreal pegcetacoplan for geographic atr...
EQS-News: Cherry SE: Erfolgreicher Analysten- und Investorentag; vorlä...
EQS-News: Cherry SE / Schlagwort(e): Kapitalmarkttag/Quartalsergebnis Cherry SE: Erfolgreicher Analysten- und Investorentag; vorläufige Zahlen zu Q1 2024 über eigener Prognose und Markterwartung; Ausblick für das laufende Jahr bekräftigt 26.04.2024 / 13:10 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Analysten- und Investorentag der Cherry SE München, 26. April 2024 – Erfolgreicher Analysten- und Investorentag; vorläufige Zahlen zu Q1 2024 über eigener Prognose und Markterwartung; Ausblick für das laufende Jahr bekräftigt Die C...
EQS-News: Cherry SE: Successful Analyst and Investor Day; preliminary ...
EQS-News: Cherry SE / Key word(s): Capital Markets Day/Quarter Results Cherry SE: Successful Analyst and Investor Day; preliminary figures for Q1 2024 above own forecast and market expectations; outlook for the current year confirmed 26.04.2024 / 13:10 CET/CEST The issuer is solely responsible for the content of this announcement. Cherry SE Analyst and Investor Day Munich, 26 April 2024 – Successful Analyst and Investor Day; preliminary figures for Q1 2024 above own forecast and market expectations; outlook for the current year confirmed Cherry SE successfully complete...
- Felix Fischer
Lucror Analytics - Morning Views Latam
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar. To request full and unrestricted access to Lucror’s research and analytics platform, please visit
Annual financial statements approved by the General Meeting of Shareho...
Annual financial statements approved by the General Meeting of Shareholders of Grigeo AB on 26th April 2024 The Annual General Meeting of Shareholders of Grigeo AB (hereinafter – the Company) was held on 26th April 2024. The meeting has approved the audited consolidated and separate financial statements of the Company for the year 2023, presented together with the consolidated annual report. There were no changes in audited financial results compared to interim consolidated report for 12 months of 2023, which was announced on 22 February 2024. The financial statements are atta...
AB „Grigeo“ visuotinio akcininkų susirinkimo 2024 m. balandžio 26 d. p...
AB „Grigeo“ visuotinio akcininkų susirinkimo 2024 m. balandžio 26 d. patvirtintos finansinės ataskaitos 2024 m. balandžio 26 d. įvyko AB „Grigeo“ (toliau – Bendrovė) eilinis visuotinis akcininkų susirinkimas. Susirinkimas patvirtino Bendrovės 2023 m. audituotas konsoliduotas ir atskiras finansines ataskaitas, pateikiamas kartu su konsoliduotu metiniu pranešimu. Lyginant su 2024 m. vasario 22 d. skelbtomis tarpinėmis 2023 m. 12 mėnesių finansinėmis ataskaitomis pokyčių audituotuose finansiniuose rezultatuose nebuvo. Finansinės ataskaitos pateikiamos priede. Atkreipiame ...
KE Holdings Inc. Releases 2023 Environmental, Social and Governance Re...
KE Holdings Inc. Releases 2023 Environmental, Social and Governance Report BEIJING, April 26, 2024 (GLOBE NEWSWIRE) -- KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE and HKEX: 2423), a leading integrated online and offline platform for housing transactions and services, today released its 2023 Environmental, Social and Governance report (the “2023 ESG report”), highlighting Beike’s commitment to sustainability under its corporate mission of “admirable service, joyful living,” and the guiding principle of “being virtuous while seeking growth.” Mr. Stanley Yongdong Peng, Co-founde...
Y-mAbs to Announce First Quarter 2024 Financial and Operating Results ...
Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024 The Company will host a conference call and webcast on Wednesday, May 8, 2024 at 8:00 a.m. ET NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its financial results for the quarter ended March 31, 2024, on Tuesday, May 7, 2024, after the close of the U.S. financial markets. The announcement will be followed by a conference call and webcast with the investment community on Wednesday, May 8, 2024, at 8:00 ...
Decisions of the Annual General Meeting of Shareholders of Grigeo AB
Decisions of the Annual General Meeting of Shareholders of Grigeo AB The Annual General Meeting of shareholders of Grigeo AB (hereinafter – the Company), was held on 26th of April 2024. The Annual General Meeting of shareholders of the Company was attended by the Chief Executive Officer of the Company, the members of the Board and the employees of the Company, who were able to provide information relating to the agenda of the Annual General Meeting of shareholders. The Annual General Meeting of shareholders adopted the following decisions: To assent to the Company's Remuneratio...
AB „Grigeo“ eilinio visuotinio akcininkų susirinkimo sprendimai
AB „Grigeo“ eilinio visuotinio akcininkų susirinkimo sprendimai 2024 m. balandžio 26 d. įvyko AB „Grigeo“ (toliau – Bendrovė) eilinis visuotinis akcininkų susirinkimas. Bendrovės eiliniame akcininkų susirinkime dalyvavo Bendrovės generalinis direktorius, valdybos nariai bei Bendrovės darbuotojai, galintys pateikti informaciją, susijusią su visuotinio akcininkų susirinkimo darbotvarke. Bendrovės eilinis visuotinis akcininkų susirinkimas priėmė šiuos sprendimus: Pritarti Bendrovės atlygio ataskaitai, kuri pateikiama kaip Bendrovės 2023 m. konsoliduotojo metinio pranešimo dalis.Pa...
JD.com to Report First Quarter 2024 Financial Results on May 16, 2024
JD.com to Report First Quarter 2024 Financial Results on May 16, 2024 BEIJING, April 26, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced that it plans to release its unaudited first quarter 2024 financial results on Thursday, May 16, 2024, before the U.S. market opens. JD.com’s management will hold a conference call at 8:00 am, Eastern Time on May 16, 2024, (8:00 pm, Beijing/Hong Kong Time on May 16, 2024) to discuss the first quarter 2024 financial resul...
Vivid Seats to Report First Quarter 2024 Financial Results
Vivid Seats to Report First Quarter 2024 Financial Results CHICAGO, April 26, 2024 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ:SEAT) (“Vivid Seats”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, will report financial results for the first quarter 2024 on Tuesday, May 7, 2024, before the U.S. stock market opens. Management will discuss the results on a webcast at 8:30 a.m. ET. The live webcast and replay can be accessed at . About Vivid Seats Founded in 200...
Evli: 2 directors
Two Directors at Evli bought/sold 25,000 shares at between 19.585EUR and 19.705EUR. The significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Ebro Foods S.A: 1 director
A director at Ebro Foods S.A bought 108,052 shares at 15.962EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Chocoladefabriken Lindt & Sprungli AG: 1 director
A director at Chocoladefabriken Lindt & Sprungli AG sold 60 shares at 10,383.333CHF and the significance rating of the trade was 99/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.